StockData
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN) stock

ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.90−0.13 (-6.40%)

Close on Nov 19, 2026Market cap $154.40MP/E –Yield –

Eledon Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Eledon Pharmaceuticals's revenue for the twelve months ending Mar 31, 2017 was $0. For fiscal 2016 it was $0. The highest annual figure on record is $0 in fiscal 2012.

Annual revenue

PeriodPeriod endValueChange
FY2016Dec 31, 2016$0–
FY2015Dec 31, 2015$0–
FY2014Dec 31, 2014$0–
FY2013Dec 31, 2013$0–
FY2012Dec 31, 2012$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More Eledon Pharmaceuticals figures

See a number that looks wrong?